Company News
Gufic Biosciences Receives Strong ESG Rating from Crisil
Gufic Biosciences Ltd intimated receipt of an ESG rating of CRISIL ESG 62 (Strong category) from Crisil ESG Ratings & Analytics Ltd.
The rating was assigned for FY 2025-26 based on publicly available
